期刊文献+

胰腺癌骨转移 被引量:1

Bone metastases of pancreatic cancer
下载PDF
导出
摘要 目的探讨胰腺癌骨转移的诊断与治疗。方法回顾性分析1999年至2003年间胰腺癌骨转移病例2例。结果经X线、B超、CT、ECT,淋巴细胞rDNA分析,肿瘤细胞学检查、肿瘤标记物检测等方法确诊。1例女性胰腺低分化腺癌,术后2年胸椎及右骶髂骨转移,接受放疗后半年后死亡;1例男性胰腺癌伴胸腰椎骨转移,在行梗阻性黄疸内引流术后1个月因肺部感染,呼吸衰竭死亡,尚未能接受对骨转移灶的治疗。结论影像学检查是发现骨转移瘤的主要方法。胰腺癌骨转移,预后差,除对原发肿瘤治疗外,应积极治疗骨转移灶以延长此类晚期患者的生存期及提高生活质量。 Objective To study the diagnosis and treatment of bone metastases of pancreatic cancer. Methods To retrospective analyses 2 cases of the bone metastases of pancreatic cancer. Results To diagnoses bone metastases of pancreatic cancer with by X-ray, ultrasound, CT, ECT, DNA analyses of lymphocyte, tumor cytological examination, tumor marker and so on. One female case with poor differentiated adenocarcinolna of pancreas was diagnosed bone metastases after 2 years of her initial pancreatic duodenectomy. She took the treatment of the radiotherapy and was dead after 6 months. Another case with pancreatic cancer has bone metastases and received the biliary-enterostomy, he was dead because of the lung infection and respiratory failure after 1 month of the operation. Conclusions The examination of the image is the main measure to find the bone metastases. It is poor prognosis in the patients of pancreatic cancer with bone metastases. In allusion to the pancreatic cancer with bone metastases beside treatment of the primary affection, at the same time to treatment the bone metastases in order to improve the survival rate and the life quality of the cases.
出处 《中国骨肿瘤骨病》 2006年第5期267-272,共6页 Chinse Journal Of Bone Tumor And Bone Disease
关键词 胰腺癌 骨转移 Pancreatic cancer Bone metastases
  • 相关文献

参考文献26

  • 1[1]Kuhlmann KF,de Castro SM,Wesseling JG,et al.Surgical treatment of pancreatic adenocaecinoma:acutual survival and prognosis factor in 343 patients.Eur J Cancer,2004,40:549-558.
  • 2[2]Iguchi H,Yasuda M,Matsuo T,et al.Clinical features and management of pancreatic cancer with bone metastases.Nippon Shokakibyo Gakkai Zasshi,2004,101:872-878.
  • 3[3]Uchida A,Wakabayashi H,Okuyama N,et al.Metastatic bone disease:pathogenesis and new strategies for treatment.J Orthop Sci,2004,9:415-420.
  • 4[4]Parikh SN,Grawford AH.Orthopaedic implications in the management of pediatric vertebral and spinal cord tumors:a retrospective review.Spine,2003,28:2390-2396.
  • 5[5]Iguchi H,Yasuda M,Matsuo T,et al.Clinical features and management of pancreatic cancer with bone metastases.Nippon Shokakibyo Gakkai Zasshi,2004,101:872-878.
  • 6[6]Ziegler EA,Bohl J,Maurer J.Bilateral progressive hearing loss as the first manifestation of metastatic carcinoma of the head of the pancreascase report.Laryngorhinootologie,2001,80:436-438.
  • 7李前伟,谭天秩.^(18)F-FDG PET在胰腺癌诊疗中的应用[J].中国肿瘤临床,2006,33(5):296-299. 被引量:4
  • 8刘永昌.正电子发射断层显象对胰腺癌的诊断及其价值[J].中国新药与临床杂志,2004,23(2):122-123. 被引量:10
  • 9张辉,刘健,所广军,徐曼珠,赵中辛,宋炯,程超.氟脱氧葡萄糖SPECT符合探测显像在胰腺癌诊断中的应用[J].中华肝胆外科杂志,2003,9(8):460-462. 被引量:2
  • 10[10]Higashi T,Saga T,Nakamoto Y,et al.Diagnosis of pancreatic cancer using fleuorine-18 fluorodexyglucose positron emission tomography (18FDG PET) usefulness and limition in "clinical reality".Ann Nucl Med,2003,17:261-279.

二级参考文献86

  • 1孙中行.临床流行病学[M].沈阳:辽宁省科学技术出版社,1996.153-156.
  • 2吴肇汉.胰腺与壶腹周围肿瘤[A].汤钊猷.现代肿瘤学[C].上海:上海医科大学出版社,1993.857—866.
  • 3[1]RESKE SN, GRILLENBERGER KG, GLATTING G, et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma[J]. J Nud Med, 1997, 38(9):1344-1348.
  • 4[2]DIEDERICHS CG. Pancreatic cancer[A]. RUHLMAN J, OEHR P, BIERSACH HJ. PET in ocology. 1st ed[M]. Berlin: Springer-Verlay, 1999. 128-134.
  • 5[3]INOKUMA T, TAMAKI N, TORIZUKA, T, et al. Evaluation of pancreatic tumors with positron emission tomography and 18F-fluorodeoxyglucose: comparison with CT and US[J]. Radiology, 1995, 195(2):345-352.
  • 6[4]-[3] See above
  • 7Stott MA,Farrands PA,Guver PB,et al.Ultrasound of the common bile duct in patients undergoing cholecystectomy.JCU,1991,19:73.
  • 8Lomas DJ,Bearcroft PW,Gimson AE.MR cholangiopancreatography:prospective comparison of a breathhold 2D projection technique with diagnostic MRCP.Eur Radiol,1999,9:1411-1417.
  • 9Reske SN, GriUenberger KG, Glatfing G, et al. Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma[J].J Nucl Medl, 1997, 38(9):1344-1348.
  • 10Higashi T, Saga T, Nakamoto Y, et al. Relationship between retendon index in dual-phase (18)F-FDG PET, and hexokinase-Ⅱ and glucose transporter-1 expression in pancreatic cancer [J]. J Nucl Med, 2002, 43 (2): 173 - 180.

共引文献86

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部